Opening book details…
About this Medicine article
Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial by Keefe, S.M. ;Hoffman-Censits, J. ;Cohen, R.B. ;Mamtani, R. ;Heitjan, D. ;Eliasof, S. ;Nixon, A. ;Turnbull, B. ;Garmey, E.G. ;Gunnarsson, O. ;Waliki, M. ;Ciconte, J. ;Jayaraman, L. ;Senderowicz, A. ;Tellez, A.B. ;Hennessy, M. ;Piscitelli, A. ;Vaughn, D. ;Smith, A. ;Haas, N.B. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Keefe, S.M. ;Hoffman-Censits, J. ;Cohen, R.B. ;Mamtani, R. ;Heitjan, D. ;Eliasof, S. ;Nixon, A. ;Turnbull, B. ;Garmey, E.G. ;Gunnarsson, O. ;Waliki, M. ;Ciconte, J. ;Jayaraman, L. ;Senderowicz, A. ;Tellez, A.B. ;Hennessy, M. ;Piscitelli, A. ;Vaughn, D. ;Smith, A. ;Haas, N.B.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2016
- Language
- EN
- Field
- Medicine (Health Sciences)